In skeletal muscle, CCN2/CTGF levels are elevated in diverse neuromuscular diseases, including muscular dystrophies of different etiology, muscle denervation, neurodegenerative diseases, and damage for muscle overuse [22,55,62,90,93,94,95,96,97,98,99,100,101]. This evidence concerns the gene CCN2 and neurodegenerative disease.